RedHill Biopharma (RDHL) Change in Inventory (2017 - 2023)

RedHill Biopharma (RDHL) has reported Change in Inventory for 7 consecutive years, with -$3.3 million the latest figure, recorded in Q2 2023.

• On a quarterly basis, Change in Inventory fell 229.77% year-over-year to -$3.3 million in Q2 2023; TTM through Jun 2023 was $2.5 million, a 186.13% increase from a year earlier, with the FY2025 full-year figure at -$375000.0, down 150.81% from the prior year.
• Change in Inventory was -$3.3 million for Q2 2023 at RedHill Biopharma, down from $5.1 million in the prior quarter.
• Over five years, Change in Inventory peaked at $5.1 million in Q1 2023 and troughed at -$4.4 million in Q3 2021.
• A 5-year average of -$466888.9 and a median of -$528500.0 in 2019 frame the typical range for Change in Inventory.
• Across the five-year window, Change in Inventory plunged 1905.06% in 2020 and soared 857.25% in 2023, its largest moves.
• Over 5 years, Change in Inventory stood at $79000.0 in 2019, then sank by 1905.06% to -$1.4 million in 2020, then declined by 18.93% to -$1.7 million in 2021, then surged by 192.87% to $1.6 million in 2022, then slumped by 310.35% to -$3.3 million in 2023.
• The last three Change in Inventory figures came in at -$3.3 million (Q2 2023), $5.1 million (Q1 2023), and $1.6 million (Q4 2022), per Business Quant data.